Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study.
Neuropsychopharmacology reports · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAlzheimer DiseaseFemaleMaleCross-Sectional StudiesAgedHealthy AgingReceptors, Nerve Growth FactorDepressionBiomarkersAged, 80 and overNerve Tissue ProteinsReceptor, Nerve Growth FactorAlzheimer's diseasecerebrospinal fluidhealthy aginglate‐life depressionp75 neurotrophin receptor ectodomain
Come citare questo studio
Wataru Omori, Naoto Kajitani, Mami Okada-Tsuchioka, Minoru Takebayashi. (2026). Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study.. Neuropsychopharmacology reports. DOI: 10.1002/npr2.70171
Consulta la pubblicazione originale ↗